News Blog

Monday, 19 December 2022 10:52

Make Your Impact Felt in Primary Healthcare, FIP President Urges Pharmacists

Rate this item
(0 votes)

Make Your Impact Felt in Primary Healthcare, FIP President Urges Pharmacists

President of the International Pharmaceutical Federation (FIP), Mr Dominique Jordan, has urged pharmacists across the globe to strive to make impressive contributions in the healthcare space by making huge impact in primary healthcare.

Jordan made this disclosure to Pharmanews in an exclusive interview on the outcome of the recently concluded 80th FIP World Congress of Pharmacy and Pharmaceutical Sciences, held in Serville, Spain. He added that, towards the realisation of this goal, the Federation has been building on three key areas of work, which are non-communicable diseases, prevention and patient safety.

Emphasising the crucial roles of primary healthcare in any healthcare delivery system, Jordan noted that no healthcare sector can survive without a solid channel in reaching the grassroots.

He said this is the reason the federation has been specifically committed to primary healthcare for the past four years, stressing that activities are in top gear towards celebrating the fourth anniversary of this commitment with a Global Summit.

Speaking on other roles pharmacists can play in primary healthcare, aside from vaccination, he mentioned screening of  people for increased risk of cardiovascular disease, as done in Australia; Prevention of HIV infections by prescribing antiretrovirals for pre- and post-exposure prophylaxis, as done in Brazil; improving tuberculosis patients’ health and helping stop the spread of the disease, as done in India; management of diabetes patients, as done in Lebanon; and detection of people at risk of colorectal cancer and screening, as done by Switzerland community pharmacists, among others.

 

Source: PharmaNews

Read 333 times

Information

NIROPHARM is dedicated to working to improve and enhance the quality of service to the Nation, public (local and international) Image, and the scope of the Nigerian Pharmaceutical Industry who face a number of challenges. 

Some of the challenges that NIROPHRM is set  to tackle with all the resources it has at its disposal include: High cost of funds, Poor infrastructure, Poor IPR protection, Chaotic drug distribution, Lack of data for planning, High level of Counterfeiting, Low capacity of Regulatory Agencies, Regulatory Agency, not computerized, Poor surveillance particularly at the land borders